^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
PredicineATLAS™

Company:
Predicine
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
PredicineATLAS™ is 600-gene CLIA-certified, pan-cancer liquid biopsy test for comprehensive variant profiling, TMB & MSI assessment using next generation sequencing.
Cancer:
Biliary Tract Cancer, Solid Tumor
Gene:
HRD (Homologous Recombination Deficiency), MSI (Microsatellite instability), TMB (Tumor Mutational Burden)
Method:
Next-Generation Sequencing (NGS)